146 related articles for article (PubMed ID: 36524402)
1. Emerging therapeutic targets for retinoblastoma.
Manukonda R; Narayana RV; Kaliki S; Mishra DK; Vemuganti GK
Expert Opin Ther Targets; 2022 Nov; 26(11):937-947. PubMed ID: 36524402
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
[TBL] [Abstract][Full Text] [Related]
3. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
4. The role of intravitreal chemotherapy for retinoblastoma.
Manjandavida FP; Shields CL
Indian J Ophthalmol; 2015 Feb; 63(2):141-5. PubMed ID: 25827545
[TBL] [Abstract][Full Text] [Related]
5. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
6. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival.
Naseripour M; Sedaghat A; Mirshahi R; Abdolalizadeh P; Koushki A; Faranoush M; Ghorbani M; Kashkouli MB; Sadeghipour A; Chaibakhsh S; Mehrvar A
Eur J Ophthalmol; 2023 Jan; 33(1):574-586. PubMed ID: 35414292
[TBL] [Abstract][Full Text] [Related]
7. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
8. A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.
Chronopoulos A; Babst N; Schiemenz C; Schutz JS; Heindl LM; Ranjbar M; Kakkassery V
Neurosignals; 2022 Nov; 30(S1):39-58. PubMed ID: 36354963
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.
Rathore S; Verma A; Ratna R; Marwa N; Ghiya Y; Honavar SG; Tiwari A; Das S; Varshney A
Indian J Ophthalmol; 2023 Jul; 71(7):2662-2676. PubMed ID: 37417104
[TBL] [Abstract][Full Text] [Related]
12. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
13. Failure of globe conservation in a case of adult onset retinoblastoma.
Khetan V; Bindu A; Kamat P; Kumar SK
Middle East Afr J Ophthalmol; 2014; 21(4):358-60. PubMed ID: 25371646
[TBL] [Abstract][Full Text] [Related]
14. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
15. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
16. [Pay attention to the application of the international intraocular retinoblastoma classification and sequential multiple modality treatment].
Fan XQ
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):561-565. PubMed ID: 28851194
[TBL] [Abstract][Full Text] [Related]
17. Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center.
Yoo KH; Sohn WY; Sung KW; Jung HL; Koo HH; Oh SY; Kang SW
J Korean Med Sci; 2002 Dec; 17(6):817-22. PubMed ID: 12483008
[TBL] [Abstract][Full Text] [Related]
18. Review: New horizons in retinoblastoma treatment: an updated review article.
Azimi F; Mirshahi R; Naseripour M
Mol Vis; 2022; 28():130-146. PubMed ID: 36034735
[TBL] [Abstract][Full Text] [Related]
19. Current management strategies for intraocular retinoblastoma.
Kim JW; Abramson DH; Dunkel IJ
Drugs; 2007; 67(15):2173-85. PubMed ID: 17927283
[TBL] [Abstract][Full Text] [Related]
20. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
